Upstream commences testing Marker C on the APACE cohort
The next phase of development is now underway, with the commencement of testing Marker C on the APACE cohort - 1,500 chest pain patients from Switzerland who presented to the emergency department.
The aim of this testing is to further determine the accuracy of Marker C in identifying patients with unstable angina, to help triage the troponin grey zone.
